tiprankstipranks
Takeda Pharmaceutical Co Ltd (JP:4502)
TSE/TYO:4502

Takeda Pharmaceutical Co (4502) Ownership - Who Owns Takeda Pharmaceutical Co?

0 Followers

Takeda Pharmaceutical Co (4502) Ownership Overview

0.00%3.54%8.45%88.01%
8.45% Other Institutional Investors
88.01% Public Companies and
Individual Investors
The ownership structure of Takeda Pharmaceutical Co (JP:4502) stock is a mix of institutional, retail and individual investors. Approximately 11.99% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 88.01% is owned by Public Companies and Individual Investors.
The ownership structure of Takeda Pharmaceutical Co (JP:4502) stock is a mix of institutional, retail and individual investors. Approximately 11.99% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 88.01% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 11, 2023
Ramona Sequeira
Divisional President
Sold$1055488
Jul 11, 2023
Gabriele Ricci
Chief Technology Officer
Sold$146076
Jul 11, 2023
Julie Kim
Divisional President
Sold$455139
Jul 11, 2023
Thomas Wozniewski
Supply Chain Director
Sold$74118

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
50,660,661Institution3.20%1,313,681,600
25,850,788Institution1.63%670,336,784
20,987,563Institution1.33%544,228,496
12,133,328Institution0.77%314,629,328
8,707,187Institution0.55%225,786,066
6,870,116Institution0.43%178,148,978
6,500,621Institution0.41%168,567,603
5,756,918Institution0.36%149,282,641
5,633,104Institution0.36%146,072,010
5,127,742Institution0.32%132,967,478

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
20,987,563Institution1.33%544,228,496
6,870,116Institution0.43%178,148,978
5,756,918Institution0.36%149,282,641
4,777,350Institution0.30%123,881,463
3,531,400Institution0.22%91,572,733
3,152,800Institution0.20%81,755,257
2,255,011Institution0.14%58,474,690
1,857,515Institution0.12%48,167,221
1,818,400Institution0.11%47,152,930
947,299Institution0.06%24,564,410

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,679,313Institution0.11%7,012,811,088
1,679,313Institution0.11%7,012,811,088
1,679,313Institution0.11%7,012,811,088
1,679,313Institution0.11%7,012,811,088
1,679,313Institution0.11%7,012,811,088
1,589,797Institution0.10%6,626,273,896
1,589,797Institution0.10%6,626,273,896
1,435,651Institution0.09%5,969,436,858
1,435,651Institution0.09%5,969,436,858
1,435,651Institution0.09%5,969,436,858

FAQ

Who Owns Takeda Pharmaceutical Co Ltd (JP:4502)?
According to the latest TipRanks data, approximately 8.45% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 88.01% is held by retail investors.
    What percentage of Takeda Pharmaceutical Co Ltd (JP:4502) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 8.45% of Takeda Pharmaceutical Co Ltd (JP:4502) stock is held by institutional investors.
      What percentage of Takeda Pharmaceutical Co Ltd (JP:4502) stock is held by retail investors?
      According to the latest TipRanks data, approximately 88.01% of Takeda Pharmaceutical Co Ltd (JP:4502) stock is held by retail investors.
        Who owns the most shares of Takeda Pharmaceutical Co Ltd (JP:4502)?
        iShares owns the most shares of Takeda Pharmaceutical Co Ltd (JP:4502).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis